Showing 1 - 20 results of 1,360 for search '(( status ((((a decrease) OR (step decrease))) OR (small decrease)) ) OR ( _ patent decrease ))', query time: 0.53s Refine Results
  1. 1

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Data Sheet 1_Improvement of pulmonary edema and respiratory status after transcatheter PDA closure in the smallest and most premature infants.docx by Ahmad Chmaisse (8829737)

    Published 2025
    “…</p>Results<p>40% of patients weaned respiratory support. x-ray haziness change was not significantly different between groups (p = 0.086), however trended toward significance. 59% had decreased haziness and 16% had a marked decrease. Smaller, younger infants were more likely to wean support and have improved edema.…”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20